PCSA
Processa Pharmaceuticals Inc
NASDAQ: PCSA · HEALTHCARE · BIOTECHNOLOGY
$2.70
+1.89% today
Updated 2026-04-30
Market cap
$7.93M
P/E ratio
—
P/S ratio
1,320.06x
EPS (TTM)
$-10.36
Dividend yield
—
52W range
$2 – $20
Volume
0.1M
Processa Pharmaceuticals Inc (PCSA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-160000.00 | $-710000.00 | $-1.89M | $-2.54M | $-2.70M | $-871906.00 | $-871906.00 | $-1.65M | $-3.71M | $-2.75M | $-3.14M | $-8.72M | $-9.61M | $-8.06M | $-11.25M | $-11.39M |
| Capital expenditures | $0.00 | $0.00 | $334338.00 | $27674.00 | $48299.00 | $1399.00 | $1399.00 | $20622.00 | $20500.00 | $0.00 | $4.00 | $0.00 | $3.00 | $2776.00 | $3244.00 | $5.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | $456998.00 | $216083.00 | $231524.00 | — | $96929.00 | $6691.00 | $74063.00 | $510478.00 | $2.73M | $3.41M | $8.83M | $1.06M | $629514.00 | $857550.00 |
| Free cash flow | $-160000.00 | $-710000.00 | $-2.22M | $-2.57M | $-2.74M | $-873305.00 | $-873305.00 | $-1.68M | $-3.73M | $-2.75M | $-3.14M | $-8.72M | $-9.61M | $-8.07M | $-11.25M | $-11.39M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | — | $767247.00 | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | — | $14.72M | — | — | — | — | — |